Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.

Corticosteroid-binding globulin (CBG) is the specific carrier of circulating glucocorticoids, but evidence suggests that it also plays an active role in modulating tissue glucocorticoid activity. CBG polymorphisms affecting its expression or affinity for glucocorticoids are associated with chronic p...

Full description

Bibliographic Details
Main Authors: José Gulfo, Joana Pérez de San Román, Angelo Ledda, Felix Junyent, María J Ramírez, Francisco J Gil-Bea, Montserrat Esteve, Mar Grasa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0246930
_version_ 1818898375682031616
author José Gulfo
Joana Pérez de San Román
Angelo Ledda
Felix Junyent
María J Ramírez
Francisco J Gil-Bea
Montserrat Esteve
Mar Grasa
author_facet José Gulfo
Joana Pérez de San Román
Angelo Ledda
Felix Junyent
María J Ramírez
Francisco J Gil-Bea
Montserrat Esteve
Mar Grasa
author_sort José Gulfo
collection DOAJ
description Corticosteroid-binding globulin (CBG) is the specific carrier of circulating glucocorticoids, but evidence suggests that it also plays an active role in modulating tissue glucocorticoid activity. CBG polymorphisms affecting its expression or affinity for glucocorticoids are associated with chronic pain, chronic fatigue, headaches, depression, hypotension, and obesity with an altered hypothalamic pituitary adrenal axis. CBG has been localized in hippocampus of humans and rodents, a brain area where glucocorticoids have an important regulatory role. However, the specific CBG function in the hippocampus is yet to be established. The aim of this study was to investigate the effect of the absence of CBG on hippocampal glucocorticoid levels and determine whether pathways regulated by glucocorticoids would be altered. We used cbg-/- mice, which display low total-corticosterone and high free-corticosterone blood levels at the nadir of corticosterone secretion (morning) and at rest to evaluate the hippocampus for total- and free-corticosterone levels; 11β-hydroxysteroid dehydrogenase expression and activity; the expression of key proteins involved in glucocorticoid activity and insulin signaling; microtubule-associated protein tau phosphorylation, and neuronal and synaptic function markers. Our results revealed that at the nadir of corticosterone secretion in the resting state the cbg-/- mouse hippocampus exhibited slightly elevated levels of free-corticosterone, diminished FK506 binding protein 5 expression, increased corticosterone downstream effectors and altered MAPK and PI3K pathway with increased pY216-GSK3β and phosphorylated tau. Taken together, these results indicate that CBG deficiency triggers metabolic imbalance which could lead to damage and long-term neurological pathologies.
first_indexed 2024-12-19T19:31:05Z
format Article
id doaj.art-da1d07cde819426f91010b41788d9a78
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T19:31:05Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-da1d07cde819426f91010b41788d9a782022-12-21T20:08:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e024693010.1371/journal.pone.0246930Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.José GulfoJoana Pérez de San RománAngelo LeddaFelix JunyentMaría J RamírezFrancisco J Gil-BeaMontserrat EsteveMar GrasaCorticosteroid-binding globulin (CBG) is the specific carrier of circulating glucocorticoids, but evidence suggests that it also plays an active role in modulating tissue glucocorticoid activity. CBG polymorphisms affecting its expression or affinity for glucocorticoids are associated with chronic pain, chronic fatigue, headaches, depression, hypotension, and obesity with an altered hypothalamic pituitary adrenal axis. CBG has been localized in hippocampus of humans and rodents, a brain area where glucocorticoids have an important regulatory role. However, the specific CBG function in the hippocampus is yet to be established. The aim of this study was to investigate the effect of the absence of CBG on hippocampal glucocorticoid levels and determine whether pathways regulated by glucocorticoids would be altered. We used cbg-/- mice, which display low total-corticosterone and high free-corticosterone blood levels at the nadir of corticosterone secretion (morning) and at rest to evaluate the hippocampus for total- and free-corticosterone levels; 11β-hydroxysteroid dehydrogenase expression and activity; the expression of key proteins involved in glucocorticoid activity and insulin signaling; microtubule-associated protein tau phosphorylation, and neuronal and synaptic function markers. Our results revealed that at the nadir of corticosterone secretion in the resting state the cbg-/- mouse hippocampus exhibited slightly elevated levels of free-corticosterone, diminished FK506 binding protein 5 expression, increased corticosterone downstream effectors and altered MAPK and PI3K pathway with increased pY216-GSK3β and phosphorylated tau. Taken together, these results indicate that CBG deficiency triggers metabolic imbalance which could lead to damage and long-term neurological pathologies.https://doi.org/10.1371/journal.pone.0246930
spellingShingle José Gulfo
Joana Pérez de San Román
Angelo Ledda
Felix Junyent
María J Ramírez
Francisco J Gil-Bea
Montserrat Esteve
Mar Grasa
Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.
PLoS ONE
title Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.
title_full Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.
title_fullStr Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.
title_full_unstemmed Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.
title_short Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.
title_sort corticosteroid binding globulin cbg deficient mice show high py216 gsk3β and phosphorylated tau levels in the hippocampus
url https://doi.org/10.1371/journal.pone.0246930
work_keys_str_mv AT josegulfo corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT joanaperezdesanroman corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT angeloledda corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT felixjunyent corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT mariajramirez corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT franciscojgilbea corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT montserratesteve corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus
AT margrasa corticosteroidbindingglobulincbgdeficientmiceshowhighpy216gsk3bandphosphorylatedtaulevelsinthehippocampus